KZA 0.00% 8.0¢ kazia therapeutics limited

Ann: Kazia releases final data from P2 paxalisib trial, page-5

  1. 540 Posts.
    lightbulb Created with Sketch. 201
    Enough to trigger a Priority Review Voucher from the FDA ?
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.